HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
about
Pseudogenes in Human CancermiRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarksHigh mobility group a proteins as tumor markersHMGA1-pseudogenes and cancerMolecular Evolution of PTEN Pseudogenes in MammalsRegistered report: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAsHMGA1-pseudogene overexpression contributes to cancer progressionCompetitive endogenous RNA network: potential implication for systemic lupus erythematosus.Protein-Coding Genes' Retrocopies and Their Functions.The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas.Genome-wide gene expression analysis of peripheral leukocytes in relation to the male predominance of Guillain-Barre syndrome: differential gene expression between male and female patients.Pseudogene-expressed RNAs: a new frontier in cancers.The competing endogenous RNA network of CYP4Z1 and pseudogene CYP4Z2P exerts an anti-apoptotic function in breast cancer.The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB.TP53INP1 3'-UTR functions as a ceRNA in repressing the metastasis of glioma cells by regulating miRNA activity.HMGA1-pseudogene expression is induced in human pituitary tumors.CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression.High Mobility Group A proteins in esophageal carcinomasHMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism.Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes.PTTG3P promotes gastric tumour cell proliferation and invasion and is an indicator of poor prognosis.The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism.Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas.A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.Long non-coding RNA MT1DP shunts the cellular defense to cytotoxicity through crosstalk with MT1H and RhoC in cadmium stress.miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1.
P2860
Q26781044-41A058C3-209F-47F9-BCD9-690A4620F729Q26781836-4E1F5AF5-DF5E-4360-981E-15315AB2CCD3Q26853205-2CC73DE4-3C71-42BC-8A4F-49CD09A09930Q28072498-3EB9C6F7-A146-42A6-A729-8F46AF4669FCQ28588224-0A2BAFB9-8BED-4C7B-943E-87CF568A7B19Q28602897-95B48CB3-4202-42F7-AFC1-77BA7B91B6A4Q28608654-A0F587D2-86F6-46C4-A0D9-1F736FD2283DQ30234822-D6FF7739-77DB-44C9-8DCE-CBFCAE3FE820Q33613535-4DBECE80-BB3E-40B9-BE18-C374E24435F2Q34463863-FE21AE24-A698-49D5-859F-B91EA175B101Q35747250-86EED848-93B7-45BB-A374-068525BE910AQ38462702-683E3622-DA88-430E-8570-AC5B4A56EE8DQ38667912-63CA7A2B-2DDE-4DD3-9CF6-C54DDC64F94CQ38714899-FC436F07-8273-4A3D-81B0-B9DF6A191909Q38718999-4E7D8DE0-CFD4-427C-A857-D728D9464C63Q38762392-03B4BD4E-930B-4D49-B66E-C57A3645C024Q38884465-7984746A-4FE6-4068-AEAB-C402E6419AC8Q38919185-EA29C9D1-DDD1-405B-A086-37F408A29E2CQ41113453-89418F5B-CC88-48C3-B008-1D6D594FDAB0Q42364945-B95B0635-36EE-4152-B9EF-60C37B04737DQ42826953-26563F29-3989-4AAA-AD44-69F399DA38CFQ47131117-5F41CF2C-173C-42C8-8631-7A467FFCD66AQ47136898-6B24551E-94DD-45A0-96A6-108F11F791D3Q47158070-29C1CF59-2013-4765-A32B-2CD4CF8DB9B0Q51319949-38E273A3-8A28-4182-A891-696E6887FEEFQ52366309-CAE07F64-0449-46BB-910A-412DF11346F9Q55315505-58DB06F2-DC6B-47FF-81FD-8669EA40003A
P2860
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@ast
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@en
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@nl
type
label
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@ast
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@en
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@nl
prefLabel
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@ast
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@en
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@nl
P2093
P2860
P356
P1433
P1476
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
@en
P2093
Alfredo Fusco
Antonella Federico
Floriana Forzati
Francesco Esposito
Giovanna Maria Pierantoni
Mara Tornincasa
Maria Grazia Petti
P2860
P304
P356
10.18632/ONCOTARGET.2202
P407
P577
2014-09-30T00:00:00Z